The approach in both preclinical animal models of type 2 diabetes and in clinical studies of patients with type 2 diabetes has shown to increase levels of intact GLP-1 and GIP, ultimately leading to meaningful improvements in overall glucose homeostasis [8]–[10]. The gene discussed is GIP; the disease is type 2 diabetes mellitus.